RNA chemical modifications change how fast and in what order the spliceosome assembles on pre-mRNA by altering local RNA structure, protein recruitment, and RNA–protein dynamics. The best-studied mark, m6A, installed by the METTL3/METTL14 complex and removed by demethylases, is reversible and dynamic, which makes it a kinetic regulator rather than a static label. Work by Chuan He at University of Chicago established the reversibility and regulatory potential of m6A, linking methylation dynamics to multiple steps in RNA metabolism. Those dynamic changes influence whether spliceosomal components recognize nearby splice sites rapidly or are delayed by competing RNA structures or bound factors.
Mechanisms that change assembly speed
Modifications can speed assembly by creating binding sites for nuclear reader proteins or slow it by stabilizing alternative RNA conformations. For example, methylation can recruit nuclear YTH family readers that in turn promote binding of serine/arginine-rich splicing factors, biasing early commitment complexes toward particular exon choices. Conversely, base isomerizations such as pseudouridine alter local base pairing and can strengthen or weaken intronic secondary structures, making U1 and U2 snRNP engagement faster or slower in a context-dependent way. Laboratory investigations of spliceosome biochemistry and factor requirements, including foundational splicing mechanism work from Adrian R. Krainer at Cold Spring Harbor Laboratory, show that even modest changes in RNA accessibility or transient protein interactions have measurable effects on assembly kinetics.
Consequences for cells, tissues, and disease
Kinetic shifts in spliceosome assembly propagate to altered alternative splicing patterns, affecting isoform ratios that are critical during development and in specialized tissues such as the brain where alternative splicing is extensive. Environmentally induced changes to modification writer or eraser activity—for example during stress or metabolic change—can reprogram splicing decisions, with consequences for cell identity and stress responses. Misregulation of writers, erasers, or readers has been associated with cancer and neurodevelopmental disorders through perturbation of the kinetic balance that normally ensures correct splice-site selection. At the population and territorial level, tissue-specific expression of modification enzymes and species-specific sequence contexts create cultural and physiological variability in how modifications tune spliceosomal timing. Overall, RNA modifications act as kinetic modulators that integrate enzymatic activity, RNA structure, and RNA-binding proteins to shape spliceosome assembly and thereby control gene expression outcomes.